{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T06:32:38Z","timestamp":1785047558616,"version":"3.55.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T00:00:00Z","timestamp":1728604800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005722","name":"LMU Munich","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005722","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Open Science"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.euros.2024.10.012","type":"journal-article","created":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T01:45:34Z","timestamp":1730425534000},"page":"154-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Genetic Predisposition to Benign Prostatic Hyperplasia: Where Do We Stand?"],"prefix":"10.1016","volume":"70","author":[{"given":"Martin","family":"Hennenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Tamalunas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian G.","family":"Stief","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euros.2024.10.012_b0005","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0090-4295(98)00569-X","article-title":"Heritability of the symptoms of benign prostatic hyperplasia and the roles of age and zonal prostate volumes in twins","volume":"53","author":"Meikle","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.euros.2024.10.012_b0010","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/01.ede.0000219723.14476.28","article-title":"Concordance rates and modifiable risk factors for lower urinary tract symptoms in twins","volume":"17","author":"Rohrmann","year":"2006","journal-title":"Epidemiology"},{"key":"10.1016\/j.euros.2024.10.012_b0015","first-page":"293","article-title":"Benign and malignant prostatic neoplasms: human studies","volume":"49","author":"Partin","year":"1994","journal-title":"Recent Prog Horm Res"},{"key":"10.1016\/j.euros.2024.10.012_b0020","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.eururo.2014.01.007","article-title":"Systematic review and meta-analysis of candidate gene association studies of lower urinary tract symptoms in men","volume":"66","author":"Cartwright","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2024.10.012_b0025","doi-asserted-by":"crossref","first-page":"33953","DOI":"10.18632\/oncotarget.15424","article-title":"Genetic association between PSA-158G\/A polymorphism and the susceptibility of benign prostatic hyperplasia: a meta-analysis","volume":"8","author":"Su","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.euros.2024.10.012_b0030","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3389\/fphys.2017.00688","article-title":"Association between SRD5A2 rs523349 and rs9282858 polymorphisms and risk of benign prostatic hyperplasia: a meta-analysis","volume":"8","author":"Zeng","year":"2017","journal-title":"Front Physiol"},{"key":"10.1016\/j.euros.2024.10.012_b0035","doi-asserted-by":"crossref","first-page":"6713","DOI":"10.1007\/s11033-014-3554-2","article-title":"Meta-analysis of vitamin D receptor gene polymorphisms and benign prostatic hyperplasia risk","volume":"41","author":"Zeng","year":"2014","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.euros.2024.10.012_b0040","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13643-022-01914-7","article-title":"Systematic review and meta-analysis of candidate gene association studies of benign prostate hyperplasia","volume":"11","author":"Lin","year":"2022","journal-title":"Syst Rev"},{"key":"10.1016\/j.euros.2024.10.012_b0045","doi-asserted-by":"crossref","first-page":"e6473","DOI":"10.1097\/MD.0000000000006473","article-title":"Relationship of oestrogen receptor alpha gene polymorphisms with risk for benign prostatic hyperplasia and prostate cancer in Chinese men","volume":"96","author":"Han","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.euros.2024.10.012_b0050","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.3892\/etm.2015.2755","article-title":"Association between polymorphisms of estrogen receptor 2 and benign prostatic hyperplasia","volume":"10","author":"Kim","year":"2015","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.euros.2024.10.012_b0055","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1038\/s41467-018-06920-9","article-title":"Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA","volume":"9","author":"Gudmundsson","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.euros.2024.10.012_b0060","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1007\/s40618-023-02060-0","article-title":"Genetically elevated bioavailable testosterone level was associated with the occurrence of benign prostatic hyperplasia","volume":"46","author":"Lin","year":"2023","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.euros.2024.10.012_b0065","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41391-020-00303-2","article-title":"Genome-wide association study identifies a role for the progesterone receptor in benign prostatic hyperplasia risk","volume":"24","author":"Li","year":"2021","journal-title":"Prostate Cancer Prostat Dis"},{"key":"10.1016\/j.euros.2024.10.012_b0070","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1038\/s41598-019-42427-z","article-title":"Heritability and genome-wide association study of benign prostatic hyperplasia (BPH) in the eMERGE network","volume":"9","author":"Hellwege","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.euros.2024.10.012_b0075","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/pros.23380","article-title":"A genetic variant near GATA3 implicated in inherited susceptibility and etiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS)","volume":"77","author":"Na","year":"2017","journal-title":"Prostate"},{"key":"10.1016\/j.euros.2024.10.012_b0080","article-title":"Genetically predicted alterations in thyroid function are associated with the risk of benign prostatic disease","volume":"14","author":"Huang","year":"2023","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.euros.2024.10.012_b0085","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1038\/s41467-020-15913-6","article-title":"Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes","volume":"11","author":"Liu","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.euros.2024.10.012_b0090","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.eururo.2005.08.014","article-title":"BXL628, a novel vitamin D3 analog arrests prostate growth in patients with benign prostatic hyperplasia: a randomized clinical trial","volume":"49","author":"Colli","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2024.10.012_b0095","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s00345-018-2536-8","article-title":"Cholecalciferol for the prophylaxis against recurrent urinary tract infection among patients with benign prostatic hyperplasia: a randomized, comparative study","volume":"37","author":"Safwat","year":"2019","journal-title":"World J Urol"},{"key":"10.1016\/j.euros.2024.10.012_b0100","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.3390\/nu14234943","article-title":"Inhibition of \u03b11-adrenergic, non-adrenergic and neurogenic human prostate smooth muscle contraction and of stromal cell growth by the isoflavones genistein and daidzein","volume":"14","author":"Huang","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.euros.2024.10.012_b0105","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41568-018-0087-3","article-title":"Post-GWAS in prostate cancer: from genetic association to biological contribution","volume":"19","author":"Farashi","year":"2019","journal-title":"Nat Rev Cancer"}],"container-title":["European Urology Open Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266616832401098X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266616832401098X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T22:35:08Z","timestamp":1733006108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266616832401098X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":21,"alternative-id":["S266616832401098X"],"URL":"https:\/\/doi.org\/10.1016\/j.euros.2024.10.012","relation":{},"ISSN":["2666-1683"],"issn-type":[{"value":"2666-1683","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic Predisposition to Benign Prostatic Hyperplasia: Where Do We Stand?","name":"articletitle","label":"Article Title"},{"value":"European Urology Open Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euros.2024.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}